publications | Global MPN SF 3/5

top of page

Home
About us
MPN Resources
News
Events
Webinars
Videos
You and MPN by MPN RF
Clinical Trials
The MPNs
News
Events
Webinars
Videos
You and MPN by MPN RF
Clinical Trials
The MPNs
Wellbeing
Dietary
Dietary
Contact
Shop

Everything you need to know about MPNs!

We sorted the articles into categories to help you out finding the right information.

All Posts
What are MPNs?
Diagnosed with MPN?
Living with MPNs
Women
Teens & Children
Events
MPN News
MPN Stories
Clinical Trials
Wellbeing
Dietary Breakfast
Dietary Main Course
You Tube Channel
Worldwide Day

Advancing MPN Care Through Advocacy: The Power of the 3 P's

Advancing MPN Care Through Advocacy: The Power of the 3 P's

Advancing MPN Care Through Advocacy: The Power of the 3 P's

Mar 14, 2024

Exploring Clinical Trials with MorphoSys

Exploring Clinical Trials with MorphoSys

Exploring Clinical Trials with MorphoSys

Mar 6, 2024

Empowering Women with MPNs on International Women’s Day

Empowering Women with MPNs on International Women’s Day

Empowering Women with MPNs on International Women’s Day

Mar 6, 2024

Upcoming videos for the MPN Educational Roundtables 2024!

Upcoming videos for the MPN Educational Roundtables 2024!

Upcoming videos for the MPN Educational Roundtables 2024!

Mar 5, 2024

Bridging Borders: Interview with MorphoSys

Bridging Borders: Interview with MorphoSys

Bridging Borders: Interview with MorphoSys

Feb 6, 2024

Novartis to Strengthen Oncology Pipeline with Agreement to Acquire MorphoSys AG, Including Late-Stage BET Inhibitor Pelabresib for Myelofibrosis (MF)

Novartis to Strengthen Oncology Pipeline with Agreement to Acquire MorphoSys AG, Including Late-Stage BET Inhibitor Pelabresib for Myelofibrosis (MF)

Novartis to Strengthen Oncology Pipeline with Agreement to Acquire MorphoSys AG, Including Late-Stage BET Inhibitor Pelabresib for Myelofibrosis (MF)

Feb 6, 2024

The potential of Tasquinimod in the treatment of advanced Myeloproliferative Neoplasms (MPNs): A look into the future

The potential of Tasquinimod in the treatment of advanced Myeloproliferative Neoplasms (MPNs): A look into the future

The potential of Tasquinimod in the treatment of advanced Myeloproliferative Neoplasms (MPNs): A look into the future

Feb 5, 2024

World Cancer Day and MPNs

World Cancer Day and MPNs

World Cancer Day and MPNs

Feb 2, 2024

Takeda and Protagonist Therapeutics, Inc. Enter into Worldwide License and Collaboration Agreement for Rusfertide, a Late-Stage Rare Hematology Asset

Takeda and Protagonist Therapeutics, Inc. Enter into Worldwide License and Collaboration Agreement for Rusfertide, a Late-Stage Rare Hematology Asset

Takeda and Protagonist Therapeutics, Inc. Enter into Worldwide License and Collaboration Agreement for Rusfertide, a Late-Stage Rare Hematology Asset

Feb 1, 2024

Summary of MPN Educational Roundtables: The Importance of Mental Health

Summary of MPN Educational Roundtables: The Importance of Mental Health

Summary of MPN Educational Roundtables: The Importance of Mental Health

Jan 30, 2024

EMA Approves Momelotinib: A Breakthrough for Myelofibrosis Patients

EMA Approves Momelotinib: A Breakthrough for Myelofibrosis Patients

EMA Approves Momelotinib: A Breakthrough for Myelofibrosis Patients

Jan 29, 2024

Rare Disease Day: Unveiling MPNs

Rare Disease Day: Unveiling MPNs

Rare Disease Day: Unveiling MPNs

Jan 1, 2024

ASH 2023 Insights by Prof. Ruben Mesa and Prof. Serge Verstovsek

ASH 2023 Insights by Prof. Ruben Mesa and Prof. Serge Verstovsek

ASH 2023 Insights by Prof. Ruben Mesa and Prof. Serge Verstovsek

Dec 22, 2023

Insights from Peter Loffelhardt: ASH 2023

Insights from Peter Loffelhardt: ASH 2023

Insights from Peter Loffelhardt: ASH 2023

Dec 21, 2023

Myelofibrosis Day: Raising Awareness for Myelofibrosis

Myelofibrosis Day: Raising Awareness for Myelofibrosis

Myelofibrosis Day: Raising Awareness for Myelofibrosis

Nov 24, 2023

European Health Forum Gastein 2023: European Rare Disease Research in Crisis? - A Reflective Summary

European Health Forum Gastein 2023: European Rare Disease Research in Crisis? - A Reflective Summary

European Health Forum Gastein 2023: European Rare Disease Research in Crisis? - A Reflective Summary

Nov 21, 2023

Recognizing Excellence: Highlights from the 3rd MPN Spring Symposium Awards Ceremony

Recognizing Excellence: Highlights from the 3rd MPN Spring Symposium Awards Ceremony

Recognizing Excellence: Highlights from the 3rd MPN Spring Symposium Awards Ceremony

Nov 6, 2023

Transplantation in MPN: Inspiring Ex-Patient Stories

Transplantation in MPN: Inspiring Ex-Patient Stories

Transplantation in MPN: Inspiring Ex-Patient Stories

Nov 6, 2023

Navigating Treatment Challenges in MPN: Understanding Toxicity and Patient Insights

Navigating Treatment Challenges in MPN: Understanding Toxicity and Patient Insights

Navigating Treatment Challenges in MPN: Understanding Toxicity and Patient Insights

Nov 6, 2023

Exploring MPN Innovations: A Conversation with Prof. Hugh Rienhoff

Exploring MPN Innovations: A Conversation with Prof. Hugh Rienhoff

Exploring MPN Innovations: A Conversation with Prof. Hugh Rienhoff

Nov 6, 2023

Newsletter

Sign up to receive the latest news about our activities and MPN news.

Email*

Contact

Avenida Josep Tarradellas 157, 5o 2a - Barcelona, 08029 - España

Email:
info@gmpnsf.org

Quick links

Terms and conditions

PRIVATE WHATSAPP GROUP

CONTENT TRANSLATION DISCLAIMER

Please note that this website uses AI to automatically translate its content into other languages to help people better understand the material we originally published in English. While we have made every effort to ensure the accuracy of the translation, there may be some errors or inaccuracies. We apologize for any mistakes and suggest referring to the original English text for the most accurate information.

MEDICAL DISCLAIMER

The information on this website is provided for informational purposes only and is not intended to replace the advice given by your physician or other healthcare professional. You should not use the information on this website to diagnose or treat any health problem or disease, or to prescribe any medication or other treatment.
Always seek the advice of your physician or another qualified healthcare provider with any questions you may have regarding a medical condition or treatment. Nothing contained on this website is intended for medical diagnosis or treatment. It should not be used in place of advice from your physician or another qualified healthcare provider. If you have any healthcare-related questions, call or consult your physician or another qualified healthcare provider immediately.
Always consult with your physician or another qualified healthcare provider before starting any new treatment, diet, or fitness program.

This website does not recommend self-management of health problems. The information obtained through the use of this website is not comprehensive and does not cover all diseases, ailments, physical conditions, or their treatments. If you have any healthcare-related questions, call or consult your physician or another qualified healthcare provider immediately. Never disregard medical advice or delay seeking it because of something you have read here.

Home
About us
MPN Resources
Wellbeing
- Dietary
Contact
Shop

bottom of page